Healthcare Sales & Marketing Network News: DCIS

Searching News Database: DCIS

HSMN NewsFeed - 2 May 2024
PreludeDx Welcomes Dr. Pat Whitworth as Chief Medical Officer to Drive Expansion of Precision Diagnostics
Diagnostics Oncology Personnel

HSMN NewsFeed - 8 Feb 2024
PreludeDx Appoints Chris Emery, VP of Strategic Marketing and Business Development
Diagnostics Oncology Personnel

HSMN NewsFeed - 28 Mar 2023
DCISionRT(R) by PreludeDx(TM) Receives Advanced Diagnostic Laboratory Test (ADLT) Status Approval from the Centers for Medicare & Medicaid Services
Diagnostics Oncology

HSMN NewsFeed - 21 May 2021
Modeling Data Showed Cologuard(R) Was Superior to Fecal Immunochemical Test (FIT) on Cost Effectiveness and Colorectal Cancer Incidence and Mortality
Diagnostics Oncology

HSMN NewsFeed - 14 May 2020
New Oncotype DX(R) Real-world Evidence Shows for the First Time the Practice-changing Impact of TAILORx Results
Diagnostics Oncology

HSMN NewsFeed - 6 Mar 2020
PreludeDx Announces New Response Type Biosignature Data at the 37th Annual Miami Breast Cancer Conference
Diagnostics Oncology

HSMN NewsFeed - 26 Feb 2018
Genomic Health Expands Offering to Prostate Cancer Patients with Launch of Oncotype DX(R) AR-V7 Nucleus Detect(TM) Test to Predict Treatment Response in Metastatic Disease
Diagnostics Oncology Product Launch

HSMN NewsFeed - 9 Dec 2016
Genomic Health Announces Results from Multiple Oncotype DX(R) Studies, Reinforcing its Impact in Delivering Precision Medicine to Breast Cancer Patients Around the World
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 29 Jan 2014
Genomic Health Announces Results of Oncotype DX(R) Colon Cancer Studies Presented at 2014 American Society of Clinical Oncology Gastrointestinal Cancer (ASCO GI) Symposium
Diagnostics Oncology

HSMN NewsFeed - 1 Oct 2013
Genomic Health Announces Presentation of Oncotype DX(R) Studies Reinforcing Value of Tests in Guiding Treatment for Multiple Cancers
Diagnostics Oncology

HSMN NewsFeed - 27 Apr 2011
Gamma Medica and Mayo Clinic Publish Preliminary Results of Low Dose Molecular Breast Imaging Screening Study for Women with Dense Breasts
Devices Radiology Oncology

HSMN NewsFeed - 27 Apr 2009
Further Testing With Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Cancer in Breast Cancer Patients, Changes Surgical Management
Devices Radiology Oncology

HSMN NewsFeed - 5 Dec 2008
Cryoablation of Early Invasive Ductal Breast Cancer With MRI Confirmation Shows Promising Clinical Benefits, According to Study Presented at RSNA
Devices Oncology

HSMN NewsFeed - 16 Jun 2008
Naviscan's PEM Flex(TM) Detects Smallest Cancers Better Compared to MRI in an Independent Study
Devices Radiology

HSMN NewsFeed - 29 May 2008
Breast-Specific Gamma Imaging (BSGI) Found to Be Highly Sensitive for Early Stage Breast Cancer
Devices Oncology

HSMN NewsFeed - 10 Aug 2007
BSGI Posts Higher Sensitivity than Mammography or MRI for the Detection of Ductal Carcinoma In Situ
Devices Oncology Radiology

HSMN NewsFeed - 26 Jun 2007
Imaging Diagnostic Systems Releases CT Laser Mammography Breast Cancer Clinical Study Results
Devices Radiology Oncology

HSMN NewsFeed - 8 May 2007
Novel Intraoperative Probe Effective in Assessing Lumpectomy Margins, Elusive DCIS
Devices Oncology Surgery

HSMN NewsFeed - 13 Nov 2006
Twelve Studies Evaluating Cytyc's MammoSite(R) Radiation Therapy System Presented at ASTRO Annual Meeting
Devices Oncology

Return to NewsFeed

Additional items found! 12

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 12 additional stories matching:
DCIS
(Password required)

FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!